A recent expert consensus outlines the characteristics, etiology, and management strategies for chorioretinal atrophy in patients treated with voretigene neparvovec. This consensus aims to enhance understanding and treatment approaches for this condition.
expert consensus on characteristics etiology and management of chorioretinal atrophy in patients treated with voretigene neparvovec
Original title: “Expert Consensus on Characteristics, Etiology, and Management of Chorioretinal Atrophy in Patients Treated with Voretigene Neparvovec.”